Prevalence/incidence of atrial fibrillation based on integrated medical/pharmacy claims, and association with co‐morbidity profiles/multi‐morbidity in a large US adult cohort-Reference-Cited by-同舟云学术

Prevalence/incidence of atrial fibrillation based on integrated medical/pharmacy claims, and association with co‐morbidity profiles/multi‐morbidity in a large US adult cohort

Published:2021-02-17 Issue:5 Volume:75 Page:
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int. J. Clin. Pract.

Author:

Lip Gregory Y. H.¹^ORCID,Tran George²^ORCID,Genaidy Ash³,Marroquin Patricia³,Estes Cara³,Harrelll Tracy²

Affiliation:

1. Liverpool Centre for Cardiovascular Science University of Liverpool and Liverpool Heart & Chest Hospital Liverpool UK

2. IngenioRX Indianapolis IN USA

3. Anthem Inc. Indianapolis IN USA

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.14042

Reference18 articles.

1. Atrial fibrillation

2. Incidence and Prevalence of Atrial Fibrillation and Associated Mortality Among Medicare Beneficiaries: 1993–2007

3. Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the U.S. Adult Population

4. Identifying Patients With Atrial Fibrillation in Administrative Data

5. A systematic review of validated methods for identifying atrial fibrillation using administrative data

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Implications of Polypharmacy for Patients with New-Onset Atrial Fibrillation Based on Real-World Data: Observations from the Korea National Health Insurance Service Data;Reviews in Cardiovascular Medicine;2024-05-11

2. Structured Rehabilitation for Patients with Atrial Fibrillation Based on an Integrated Care Approach: Protocol for a Prospective, Observational Cohort Study;Vascular Health and Risk Management;2023-07

3. Cardiovascular disease (CVD) outcomes and associated risk factors in a medicare population without prior CVD history: an analysis using statistical and machine learning algorithms;Internal and Emergency Medicine;2023-06-09

4. Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?;Biomedicine & Pharmacotherapy;2023-02

5. Adherence levels and patterns for multiple cardiac medications prescribed to patients with incident atrial fibrillation events;British Journal of Clinical Pharmacology;2023-01